Cromos Pharma, where the patients are

Technology Solutions

NCCN, McKesson Specialty Health, U.S. Oncology Network integrate with Elekta, Varian

Wednesday, September 25, 2013 12:26 PM

The National Comprehensive Cancer Network (NCCN), The U.S. Oncology Network and McKesson Specialty Health have inked agreements to provide future integration with Elekta and Varian that will enhance the ability to provide cancer patients with evidence-based quality care. The two oncology information systems are Elekta’s MOSAIQ and Varian’s ARIA.

More... »

CRF Health eCOA webinar series

BioTime, Jade Therapeutics ink deal

Friday, September 20, 2013 10:52 AM

BioTime, a biotechnology company that develops and markets products in regenerative medicine, has signed an exclusive sublicense agreement with Jade Therapeutics, a Salt Lake City, Utah-based developer of ophthalmic sustained-release drug delivery platforms. This new agreement supersedes the previously announced sublicense and supply agreements and expands the licensed field of use to include certain additional uses, such as BioTime’s HyStem hydrogel technology for the delivery of all potential therapeutic molecules to the human eye. Excluded from the licensed field of use is the HyStem technology for the delivery of cells with or without any molecules necessary for the therapeutic benefit of those cells, for use in making punctal plugs, for diagnostic and research reagents and for non-human applications.

More... »


Trifecta Clinical, SAFE-BioPharma partner

Friday, September 20, 2013 10:37 AM

Trifecta Clinical, a global clinical technology solutions provider, has partnered with SAFE-BioPharma to implement the SAFE-BioPharma digital identity and signature standard across its application platforms. The digital identity and signature standard provides standardized, high-assurance identity trust for cyber-transactions across the biopharmaceutical and healthcare sectors. This will accelerate the adoption of standards-based identity management, enhancing security, quality and compliance. The company also joined SAFE-BioPharma Association’s Vendor Partner Program.

More... »

AstraZeneca, Daiichi Sankyo launch reflux esophagitis iPhone app

Wednesday, September 18, 2013 01:36 PM

Daiichi Sankyo and AstraZeneca are working to educate the public about reflux esophagitis through a campaign entitled Do you experience heartburn or acid reflux? The awareness building effort seeks to ensure an accurate understanding of the symptoms of reflux esophagitis and how they affect the daily lives of patients. The campaign incorporates a variety of media, featuring TV commercials, an iPhone app and a website to encourage patients to seek the appropriate treatment and take control of their lives.

More... »

IRB Services selects Intralinks VIA

Wednesday, September 18, 2013 10:47 AM

IRB Services (Institutional Review Board Services), a global provider of research ethics review and related services for the clinical research and behavioral science industries, has selected Intralinks VIA to support all of its secure beyond the firewall collaboration needs. Intralinks is a global SaaS provider of inter-enterprise content management and collaboration solutions.

More... »

MIT awarded $25m for human computer development

Wednesday, September 18, 2013 10:42 AM

The National Science Foundation (NSF) has awarded $25 million to establish a Center for Brains, Minds and Machines at the Massachusetts Institute of Technology (MIT). The center is one of three new research centers funded this year through NSF's Science and Technology Centers: Integrative Partnerships program.

More... »

Treato Pharma launches new version of "patient voice" intelligence

Wednesday, September 18, 2013 10:40 AM

Treato, the source of "patient voice" intelligence, has announced the new version of its Treato Pharma platform for pharmaceutical companies and agencies.

More... »

Bangkok Hospital Group selects Elsevier's ClinicalKey

Monday, September 16, 2013 03:02 PM

Bangkok Hospital and Bangkok Health Research Center, both part of the Bangkok Hospital Group, have selected Elsevier's ClinicalKey as their preferred online medical information resource to support clinical decision-making and medical research.

More... »

Michael J. Fox Foundation unites industry groups for research tool development

Friday, September 13, 2013 01:07 PM

The Michael J. Fox Foundation for Parkinson's research (MJFF) has launched the Parkinson's Disease Research Tools Consortium. MJFF and seven industry partners have organized to grow the Foundation's ongoing efforts to better understand existing tools—such as preclinical models, antibodies and cell lines—and their use in laboratory experiments, as well as to develop new tools to address unmet challenges.

More... »

Almac launches TruSight tumor profiling next-generation sequencing service

Wednesday, September 11, 2013 01:37 PM

Almac has launched a tumor profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor panel as part of their biomarker discovery, development and delivery solutions.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs